https://www.selleckchem.com/pr....oducts/pirtobrutinib
Sclerotherapy was the most common primary treatment, followed by surgical resection and sirolimus. No difference in clinical response (p = 0.58) or complications (p = 0.31) was observed based on primary treatment or subtypes. Based on our institutional experience, we propose an LM subtype-based treatment algorithm for abdominal LMs. It employs a multidisciplinary approach, and results in satisfactory patient outcomes with minimal complications. Level III, retrospective comparative study. Level III, retrospective comparati
Curtir
Comentario
Compartilhar
